ArticlePatient preference and adherence2022

Patients' Preferences for Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists.

Bidur Banjara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.